HCG, the wonder of today's science

Reproductive Biology and Endocrinology

Volumn 10, Issue , 2012, Pages

  Cole, Laurence A ^a  

^a USA hCG Reference Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; SULFATE;

AUTOCRINE EFFECT; CYTOTROPHOBLAST; HORMONE STRUCTURE; HUMAN; MENSTRUAL CYCLE; NONHUMAN; PLACENTA; PREGNANCY; PROTEIN STRUCTURE; REVIEW; SCIENCE; SYNCYTIOTROPHOBLAST; UMBILICAL CORD BLOOD FLOW; CHEMICAL STRUCTURE; CHEMISTRY; FEMALE; GLYCOSYLATION; NEOPLASM; PHYSIOLOGY; REPRODUCTION; TROPHOBLAST;

CHORIONIC GONADOTROPIN; FEMALE; GLYCOSYLATION; HUMANS; MENSTRUAL CYCLE; MOLECULAR STRUCTURE; NEOPLASMS; PLACENTA; PLACENTATION; PREGNANCY; SULFATES; TROPHOBLASTS;

EID: 84858980489     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-10-24     Document Type: Review

References (144)

1. Elliott MM, Kardana A, Lustbader JW, Cole LA. Carbohydrate and Peptide structure of the α- and ß-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine 1997, 7:15-32. 10.1007/BF02778058, 9449027.
2. Laub M, Jennissen HP. Identification of the anthelix motif in the TGF-ß superfamily by molecular 3D-Rapid Prototyping. Materialwiss Werkst 2003, 34:1113-1119.
3. Lehnert SA, Akhurst RA. Embryonic expression pattern of TGF beta type-1 RNA suggests both paracrine and autocrine mechanisms of action. Development 1988, 104:263-273.
4. Lapthorn AJ, Harris DC, Littlejohn A, Lustbader JW, Canfield RE, Machin KJ. Crystal structure of hCG. Nature 1994, 369:455-461. 10.1038/369455a0, 8202136.
5. Birken S, Maydelman Y, Gawinowicz MA, Pound A, Liu Y, Hartree AS. Isolation and characterization of human pituitary chorionic gonadotropin. Endocrinology 1996, 137:1402-1411. 10.1210/en.137.4.1402, 8625917.
6. Schmitt EJ, Barros CM, Fields PA, Fields MJ, Diaz T, Kluge JM, Thatcher WW. A cellular and endocrine characterization of the original and induced corpus luteum after administration of a gonadotropin-releasing hormone agonist or human chorionic gonadotropin on day five of the estrous cycle. J Anim Sci 1996, 74:1915-1929.
7. Butler SA, Ikram MS, Mathieu S, Iles RK. The increase in bladder carcinoma cell population induced by the free beta subunit of hCG is a result of an anti-apoptosis effect and not cell proliferation. Br J Cancer 2000, 82:1553-1556. 2363404, 10789723.
8. Cole LA, Butler SA. Hyperglycosylated hCG, hCGß and Hyperglycosylated hCGß: Interchangeable Cancer Promoters. Mol Cell Endocrinol 2011,
9. Aschner B. Ueber die function der hypophyse. Pflugers Arch Gesamte Physiol 1912, 146:1-147.
10. Hirose T. Experimentalle histologische studie zur genese corpus luteum. Mitt Med Fakultd Univ ZU 1919, 23:63-70.
11. Aschheim S, Zondek B. Das Hormon des hypophysenvorderlappens. testobjekt zum Nachweis des hormons. Klin Wochenschr 1927, 6:248-252.
12. Friedman MH, Lapham ME. A simple, rapid procedure for the laboratory diagnosis of early pregnancies. Am J Obstet Gynecol 1931, 21:405-410.
13. Cole LA, Dai D, Butler SA, Leslie KK, Kohorn EI. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG-regulated neoplasia. Gynecol Oncol 2006, 102:144-149.
14. Cole LA, Khanlian SA, Kohorn EI. Evolution of the Human Brain, Chorionic Gonadotropin and Hemochorial Implantation of the Placenta: Insights into Origins of Pregnancy Failures, Preeclampsia and Choriocarcinoma. J Reprod Med 2008, 53:449-557.
15. Sasaki Y, Ladner DG, Cole LA. Hyperglycosylated hCG the source of pregnancy failures. Fertil Steril 2008, 89:1781-1786. 10.1016/j.fertnstert.2007.03.010, 17675003.
16. Guibourdenche J, Handschuh K, Tsatsaris V, Gerbaud MC, Legul F, Muller D, Evain-Brion D, Fournier T. Hyperglycosylated hCG is a marker of early human trophoblast invasion. J Clin Endocrinol Metab 2010, 95:E240-E244. 10.1210/jc.2010-0138, 20660042.
17. Handschuh K, Guibourdenche J, Tsatsari V, Guesnon M, Laurendeau I, Evain-Brion D, Fournier T. Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-a. Endocrinology 2007, 148:5011-5019. 10.1210/en.2007-0286, 17628005.
18. Shi QJ, Lei ZM, Rao CV, Lin J. Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology 1993, 132:387-395.
19. Berndt S, Blacher S, d'Hauterive PS, Thiry M, Tsampalas M, Cruz A, Pequeux C, Lorquet S, Munaut C, Noel A, Foidart JM. Chorionic gonadotropin stimulation of angiogenesis and pericyte recruitment. J Clin Endocrinol Metab 2009, 94:4567-4574. 10.1210/jc.2009-0443, 19837939.
20. Toth P, Li X, Rao CV, Lincoln SR, Sanfillipino JS, Spinnato JA, Yussman MA. Expression of functional human chorionic gonadotropin/human luteinizing hormone receptor gene in human uterine arteries. J Clin Endocrinol Metab 1994, 79:307-315. 10.1210/jc.79.1.307, 8027246.
21. Lei ZM, Reshef E, Rao CV. The expression of human chorionic gonadotropin/luteinizing hormone receptors in human endometrial and myometrial blood vessels. J Clin Endocrinol Metab 1992, 75:651-659. 10.1210/jc.75.2.651, 1379262.
22. Zygmunt M, Herr F, Keller-Schoenwetter S, Kunzi-Rapp K, Munstedt K, Rao CV, Lang U, Preissner KT. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab 2002, 87:5290-5296. 10.1210/jc.2002-020642, 12414904.
23. Herr F, Baal N, Reisinger K, Lorenz A, McKinnon T, Preissner KT, Zygmunt M. hCG in the regulation of placental angiogenesis. Results of an in vitro study. Placenta 2007, 28:(Suppl A):S85-S93.
24. Zygmunt M, Herr F, Munstedt K, Lang U, Liang OD. Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol 2003, 110(Suppl 1):S10-S18.
25. Toth P, Lukacs H, Gimes G, Sebestyen A, Pasztor N, Paulin F, Rao CV. Clinical importance of vascular hCG/LH receptors-A review. Reprod Biol 2001, 1:5-11.
26. Burton GJ, Jauniaux E, Watson A. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Am J Obstet Gynecol 1999, 181:718-724. 10.1016/S0002-9378(99)70518-1, 10486489.
27. Rao CV, Li X, Toth P, Lei ZM. Expression of epidermal growth factor, transforming growth factor-alpha and their common receptor genes in human umbilical cords. J Clin Endocrinol Metab 1995, 80:1012-1020. 10.1210/jc.80.3.1012, 7883816.
28. Rao CV, Li X, Toth P, Lei ZM, Cook VD. Novel expression of functional human chorionic gonadotropin/luteinizing hormone receptor in human umbilical cords. J Clin Endocrinol Metab 1993, 77:1706-1714. 10.1210/jc.77.6.1706, 8263161.
29. Derecka K, Stepien A, Pelliniemi L, Doboszynska T, Gawronska B, Ziecik AJ. Evidence for the presence of luteinizing hormone-chorionic gonadotrophin receptors in the pig umbilical cord. J Reprod Fertil 1999, 117:1-9. 10.1530/jrf.0.1170001, 10645239.
30. Rao CV. Nongonadal actions of LH and hCG in reproductive biology and medicine. Semin Reprod Med 2001, 19:1-119.
31. Rao CV. An overview of the past, present and future of nongonadal LH/hCG actions in reproductive biology and medicine. Semin Reprod Endocrinol 2001, 19:7-17.
32. Rao CV, Lei ZM. The past, present and future of nongonadal LH/hCG actions in reproductive biology and medicine. Mol Cell Endocrinol 2007, 269:2-8. 10.1016/j.mce.2006.07.007, 17382462.
33. Fiddes JC, Goodman HM. The cDNA for the ß-subunit of human chorionic gonadotropin suggests evolution of a gene by readthrough into the 3'-untranslated region. Nature 1980, 286:684-687. 10.1038/286684a0, 6774259.
34. Maston GA, Ruvolo M. Chorionic gonadotropin has a recent origin within primates and an evolutionary history of selection. Mol Biol Evol 2002, 19:320-334. 10.1093/oxfordjournals.molbev.a004085, 11861891.
35. Bambra CS. Purification and properties of baboon chorionic gonadotropin. J Reprod Fertil 1987, 19:421-430.
36. Crawford RJ, Tegear GW, Niall HD. The nucleotide sequence of baboon chorionic gonadotropin ß-subunit genes have diverged from the human. Gene 1986, 46:161-169. 10.1016/0378-1119(86)90400-2, 2433190.
37. Martin RD. Relative brain size and basal metabolic rate in terrestrial vertebrates. Nature 1981, 293:57-60. 10.1038/293057a0, 7266659.
38. Gibbons A. Solving the brain's energy crisis. Science 1998, 280:1345-1347. 10.1126/science.280.5368.1345, 9634409.
39. Martin RD. Scaling of the mammalian barrier: the maternal energy hypothesis. News Physiol Sci 1996, 4:149-154.
40. Cunnane SC, Herbige LS, Crawford MA. The importance of energy and nutrient supply in human brain evolution. Nutr Health 1993, 9:19-35.
41. Martin RD. Human reproduction: a comparative background for medical hypotheses. J Reprod Immunol 2003, 59:111-135. 10.1016/S0165-0378(03)00042-1, 12896817.
42. Pjenenborg R. The placental bed. Hypertens Pregnancy 1996, 15:7-23.
43. Lockett WP. Comparative development and evolution of the placenta in primates. Contrib Primatol 1974, 3:42-234.
44. Cole LA. hCG 5 independent molecules. Clin Chim Acta 2012, 413:48-65. 10.1016/j.cca.2011.09.037, 22027338.
45. Kovalevskaya G, Genbacev O, Fisher SJ, Cacere E, O'Connor JF. Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source of choriocarcinoma-like hCG. Mol Cell Endocrinol 2002, 194:147-155. 10.1016/S0303-7207(02)00135-1, 12242037.
46. Morgan FJ, Birken S, Canfield RE. The amino acid sequence of human chorionic gonadotropin. J Biol Chem 1975, 250:5247-5258.
47. Cole LA, DuToit S, Higgins TN. Total hCG tests. Clin Chim Acta 2011, 412:2216-2222. 10.1016/j.cca.2011.08.006, 21864517.
48. Cole LA. Individual Deviations in hCG Concentrations During Pregnancy. Am J Obstet Gynecol 2011, 204:349.e1-349.e7.
49. Madsen BW. Spare receptors. Clin Exp Pharmacol Physiol 1979, 6:713-714. 10.1111/j.1440-1681.1979.tb00049.x, 519912.
50. Siebers JW, Wuttke W, Engel W. hCG-binding of the rat ovary during pregnancy. Acta Endocrinol 1977, 86:173-179.
51. Marunaka M, Niisato N, Miyazaki H. New Concept of Spare Receptors and Effectors. J Membr Biol 2005, 203:31-35. 10.1007/s00232-004-0729-0, 15834687.
52. Han SW, Lei ZM, Rao CV. Homolgous down-regulation of luteinizing hormone/chorionic gonadotropin receptors by increasing the degradation of receptor transcripts in human uterine endometrial stromal cells. Biol Reprod 1997, 57:158-164. 10.1095/biolreprod57.1.158, 9209094.
53. Rao CV, Sanfillippo JS. New understanding of the biochemistry of implantation. Potential direct roles of luteinizing hormone and human chorionic gonadotropin. Endocrinology 1997, 7:107-111.
54. Jauniaux E, Bao S, Eblen A, Li X, Liu ZM, Meuris S, Rao C. hCG concentration and receptor gene expression in placenta tissue from trisomy 18 and 21. Mol Hum Reprod 2000, 6:5-10. 10.1093/molehr/6.1.5, 10611254.
55. Zondek B, Aschein S. The Zondek-Ashein pregnancy test. Can Med Assoc J 1930, 22:251-253. 381719, 20317707.
56. Wide L, Gemzell CA. An immunological pregnancy test. Acta Endocrinol 1960, 35:261-267.
57. Aono T, Goldstein DP, Taymor ML, Dolch K. A radioimmunoassay method for human pituitary luteinizing hormone (LH) and human chorionic gonadotropin (hCG) using 125I-labelled LH. Am J Obstet Gynecol 1967, 98:996-1001.
58. Vaitukaitis JL, Braunstein GD, Ross GT. A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol 1972, 113:751-758.
59. Armstrong EG, Ehrlich PH, Birken S, Schlatterer JP, Siris E, Hembree WE, Canfield RE. Use of a highly specific immunoradiometric assay for detection of human chorionic gonadotropin in urine of normal, nonpregnant or pregnant individual. J Clin Endocrinol Metab 1984, 59:867-874. 10.1210/jcem-59-5-867, 6480810.
60. Vankrieken L, Hertogh RE. Rapid automated quantification of total human chorionic gonadotropin in serum by a chemiluminescent enzyme immunoassay. Clin Chem 1995, 41:36-40.
61. Cronier L, Bastide B, Herve JC, Deleze J, Malassine A. Gap junctional communication during human trophoblast differentiation: influence of human chorionic gonadotropin. Endocrinology 1994, 135:402-408. 10.1210/en.135.1.402, 8013377.
62. Akoum A, Metz CN, Morin M. Marked increase in macrophage migration inhibitory factor synthesis and secretion in human endometrial cells in response to human chorionic gonadotropin hormone. J Clin Endocrinol Metab 2005, 90:2904-2910. 10.1210/jc.2004-1900, 15687332.
63. Matsuura T, Sugimura M, Iwaki T, Ohashi R, Kanayama N, Nishihira J. Anti-macrophage inhibitory factor antibody inhibits PMSG-hCG-induced follicular growth and ovulation in mice. J Assist Reprod Genet 2002, 19:591-595. 10.1023/A:1021219317155, 12503892.
64. Wan H, Marjan A, Cheung VW, Leenen PJM, Khan NA, Benner R, Kiekens RCM. Chorionic gonadotropin can enhance innate immunity by stimulating macrophage function. J Leukoc Biol 2007, 82:926-933. 10.1189/jlb.0207092, 17626151.
65. Kamada M, Ino H, Naka O, Irahara M, Daitoh T, Mori K, Maeda N, Maegawa M, Hirano K, Aono T. Immunosuppressive 30-kDa protein in urine of pregnant women and patients with trophoblastic diseases. Eur J Obstet Gynecol Reprod Biol 1993, 50:219-225. 10.1016/0028-2243(93)90204-P, 8262299.
66. Noonan FP, Halliday WJ, Morton H, Clunie GJA. Early pregnancy factor is immunosuppressive. Nature 1879, 278:649-651.
67. Majumdar S, Bapna BC, Mapa MK, Gupta AN, Devi PK, Subrahmanyam D. Pregnancy specific proteins: suppression of in vitro blastogenic response to mitogen by these proteins. Int J Fertil 1982, 27:66-69.
68. Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab 1990, 70:421-430. 10.1210/jcem-70-2-421, 1688865.
69. Zuo J, Lei ZM, Rao CV. Human myometrial chorionic gonadotropin/luteinizing hormone receptors in preterm and term deliveries. J Clin Endocrinol Metab 1994, 79:907-911. 10.1210/jc.79.3.907, 8077381.
70. Eta E, Ambrus G, Rao V. Direct regulation of human myometrial contractions by human chorionic gonadotropin. J Clin Endocrinol Metab 1994, 79:1582-1586. 10.1210/jc.79.6.1582, 7989459.
71. Doheny HC, Houlihan DD, Ravikumar N, Smith TJ, Morrison JJ. Human chorionic gonadotrophin relaxation of human pregnant myometrium and activation of the BKCa channel. J Clin Endocrinol Metab 2003, 88:4310-4315. 10.1210/jc.2003-030221, 12970303.
72. Edelstam G, Karlsson C, Westgren M, Löwbeer C, Swahn ML. Human chorionic gonadatropin (hCG) during third trimester pregnancy. Scand J Clin Lab Invest 2007, 67:519-525. 10.1080/00365510601187765, 17763188.
73. Goldsmith PC, McGregor WG, Raymoure WJ, Kuhn RW, Jaffe RB. Cellular localization of chorionic gonadotropin in human fetal kidney and liver. J Clin Endocrinol Metab 1983, 57:54-61.
74. Abdallah MA, Lei ZM, Li X, Greenwold N, Nakajima ST, Jauniaux E, Rao CV. Human Fetal nongonadal tissues contain human chorionic gonadotropin/luteinizing hormone receptors. J Clin Endocrinol Metab 2004, 89:952-956. 10.1210/jc.2003-030917, 14764820.
75. Rao CV. Chapter 11: Paradigm shift on the targets of hCG actions. In: Human chorionic gonadotropin (hCG). 2010, Elsevier, Oxford UK, Cole LA, .
76. McGregor WG, Raymoure WJ, Kuhn RW, Jaffe RB. Fetal tissues can synthesize a placental hormone. Evidence for chorionic gonadotropin ß-subunit synthesis by human fetal kidney. J Clin Invest 1981, 68:306-309. 10.1172/JCI110249, 370799, 7251865.
77. Ohlsson R, Larsson E, Nilsson O, Wahlstrom T, Sundstrom P. Blastocyst implantation precedes induction of insulin-like growth factor II gene expression in human trophoblasts. Development 1989, 106:555-559.
78. d'Hauterivea SP, Berndtb BS, Tsampalasa M, Charlet-Renarda C, Duboisb M, Bourgainc C, Hazoutd A, Foidartb J-B, Geenena V. Dialogue between Blastocyst hCG and Endometrial hCG/LH Receptor: Which Role in Implantation?. Gynecol Obstet Invest 2007, 64:156-160. 10.1159/000101740, 17934312.
79. Joshi NJ, Nandedkar TD. Effects of intrauterine instillation of antiserum to hCG during early pregnancy in mice. Acta Endocrinol 1984, 107:268-274.
80. Srisuparp S, Strakova Z, Fazleabas AT. The Role of Chorionic Gonadotropin (CG) in Blastocyst Implantation. Arch Med Res 2001, 32:627-634. 10.1016/S0188-4409(01)00330-7, 11750740.
81. Eblan A, Bao S, Lei ZM, Nakajima ST, Rao CV. The presence of functional luteinizing hormone/chorionic gonadotropin receptor in human sperm. J Clin Endocrinol Metab 2001, 86:2643-2648. 10.1210/jc.86.6.2643, 11397866.
82. Tsampalasa M, Grideleta V, Berndt S, Foidart J-M, Geenena V, d'Hauterive SP. Human chorionic gonadotropin: A hormone with immunological and angiogenic properties. J Reprod Immunol 2010,
83. d'Hauterive SP. Implantation: the first maternal-embryo crosstalk. , http://hdl.handle.net/2268/28418
84. Licht P, Russu V, Wildt L. On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation. Semin Reprod Med 2001, 19:37-47. 10.1055/s-2001-13909, 11394202.
85. Lei ZM, Toth P, Rao CV, Pridham D. Novel coexpression of human chorionic gonadotropin (hCG)/human luteinizing hormone receptors and their ligand hCG in human fallopian tubes. J Clin Endocrinol Metab 1993, 77:863-872. 10.1210/jc.77.3.863, 7690366.
86. Rao CV. Physiological and pathological relevance of human uterine hCG/LH receptors. J Soc Gynecol Investig 2006, 13:77-78. 10.1016/j.jsgi.2005.12.005, 16443498.
87. Cole LA. hCG and Hyperglycosylated hCG, Promoters of Villous Placenta and Hemochorial Placentation. Placenta: Functions, Development and Disease. 2012, Nova Publishers, .
88. Strott CA, Yoshimi T, Ross GT, Lipsett MB. Ovarian physiology: relationship between plasma LH and steroidogenesis by the follicle and corpus luteum; effect of hCG. J Clin Endocrinol Metab 1969, 29:1157-1167. 10.1210/jcem-29-9-1157, 5808525.
89. Schumacher A, Brachwitz N, Sohr S, Engeland K, Langwisch S, Dolaptchieva M, Alexander T, Taran A, Malfertheiner SF, Costa S-D, Zimmermann G, Nitschke C, Volk HD, Alexander H, Gunzer M, Zenclussen AC. Human Chorionic Gonadotropin Attracts Regulatory T Cells into the Fetal-Maternal Interface during Early Human Pregnancy. J Immunol 2009, 182:5488-5497. 10.4049/jimmunol.0803177, 19380797.
90. Lei ZM, Rao CV, Kornyei J, Licht P, Hiatt ES. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology 1993, 132:262-270.
91. Rao CV. Immunocytochemical localization of gonadotropin and gonadal steroid receptors in human pineal glands. J Clin Endocrinol Metab 1997, 82:2756-2757. 10.1210/jc.82.8.2756, 9253369.
92. Cole LA, Khanlian SA, Sutton JM, Davies S, Stephens N. Hyperglycosylated hCG (Invasive Trophoblast Antigen, ITA) a Key Antigen for Early Pregnancy Detection. Clin Biochem 2003, 36:647-655. 10.1016/S0009-9120(03)00108-5, 14636881.
93. Hamade AL, Nakabayashi K, Sato A, Kiyoshi K, Takamatsu Y, Laoag-Fernandez JB, Ohara N, Maruo T. Transfection of antisense chorionic gonadotropin beta gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis. J Clin Endocrinol Metab 2005, 90:4873-4879. 10.1210/jc.2004-2458, 15886246.
94. Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, Heath JK. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. Eur Mol Biol Org J 1987, 6:1899-1904.
95. Qureshi HY, Sylvester J, El Mabrouk M, Zafarullah M. TGF-beta-induced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor. J Cell Physiol 2005, 203:345-352. 10.1002/jcp.20228, 15468069.
96. Wilcox AJ, Weinberg CR, Baird DD. Risk factors for early pregnancy loss. Epidemiology 1990, 1:382-385. 10.1097/00001648-199009000-00008, 2078614.
97. Semprini AE, Simoni G. Not so efficient reproduction. Lancet 2000, 356:257-258.
98. Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. N Engl J Med 2001, 345:1400-1408. 10.1056/NEJMra000763, 11794174.
99. Cole LA. Pregnancy failures. J Reprod Immunol 2011,
100. O'Connor JF, Ellish N, Kakuma T, Schlatterer J, Kovalevskaya G. Differential urinary gonadotrophin profiles in early pregnancy and early pregnancy loss. Prenat Diagn 1998, 18:1232-1240. 10.1002/(SICI)1097-0223(199812)18:12<1232::AID-PD439>3.0.CO;2-Z, 9885014.
101. Cole LA, Shahabi S, Oz UA, Bahado-Singh RO, Mahoney MJ. Hyperglycosylated hCG (Invasive Trophoblast Antigen) Immunoassay: a New Basis for Gestational Down Syndrome Screening. Clin Chem 1999, 45:2109-2119.
102. Weinans JN, Butler SA, Mantingh A, Cole LA. Urinary hyperglycosylated hCG in first-trimester screening for chromosomal abnormalities. Prenat Diagn 2000, 20:976-978. 10.1002/1097-0223(200012)20:12<976::AID-PD962>3.0.CO;2-2, 11113909.
103. Bahado-Singh RO, Oz AU, Kingston JM, Shahabi S, Hsu CD, Cole LA. The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent pre-eclampsia. Prenat Diagn 2002, 22:478-481. 10.1002/pd.329, 12116306.
104. Cole LA, Ladner DG, Cole LA, Gutierrez JM. Production of hCG during the menstrual cycle. J Reprod Med 2009, 54:245-250.
105. Cole LA. "Background" human chorionic gonadotropin in healthy, nonpregnant women. Clin Chem 2005, 51:1765-1766. 10.1373/clinchem.2005.056507, 16189375.
106. Cole LA, Laidler L, Muller C. USA hCG Reference Service, 10 year report. Clin Biochem 2010, 43:1013-1022. 10.1016/j.clinbiochem.2010.05.006, 20493830.
107. Snyder JA, Haymond S, Parvin CA, Gronowski AM, Grenache DG. Diagnostic considerations in the measurement of human chorionic gonadotropin in aging women. Clin Chem 2005, 51:1830-1835. 10.1373/clinchem.2005.053595, 16099935.
108. Gronowowski AM, Fantz CR, Parvin CA, Sokoll LJ, Wiley CL, Wener MH, Grenache DG. Use of serum FSH to identify perimenopausal women with pituitary hCG. Clin Chem 2008, 54:652-656. 10.1373/clinchem.2007.100305, 18258666.
109. Cole LA, Hartle RJ, Laferla JJ, Ruddon RW. Detection of the free ß subunit of human chorionic gonadotropin in cultures of normal and malignant trophoblast cells, pregnancy sera, and sera of patients with choriocarcinoma. Endocrinology 1983, 113:1176-1178. 10.1210/endo-113-3-1176, 6191970.
110. Cosgrove DE, Campain JA, Cox GS. Chorionic gonadotropin synthesis by human tumor cell lines: Examination of subunit accumulation steady-state levels of mRNA and gene structure. Biochim Biophys Acta 1989, 1007:44-54.
111. Marcillac I, Cottu P, Theodore C, Lacombe MJ, Bellet D, Droz JP. Free hCG beta subunit as tumour marker in urothelial cancer. Lancet 1993, 341:1354-1355.
112. Cole LA. ß-core fragment (ß-core UGP or UGF). Tumor Marker Upd 1994, 6:69-75.
113. Gillott DJ, lles RK, Chard T. The effects of ß-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer 1996, 73:323-326. 10.1038/bjc.1996.56, 2074420, 8562337.
114. Iles RK. Human chorionic gonadotrophin and its fragments as markers of prognosis in bladder cancer. Tumor Marker Update 1995, 7:161-166.
115. Schwartz PE, Chambers JT, Taylor KJ, Cole LA, Makuch R. Urinary gonadotropin fragments. Anticancer Res 1993, 13:1722-1725.
116. Muller C, Cole LA. The Quagmire of hCG and hCG Testing in Gynecologic Oncology. Gynecol Oncol 2009, 112:663-672. 10.1016/j.ygyno.2008.09.030, 19007977.
117. Rosen SW, Calvert I, Weintraub BD, Tseng JS, Rabson AS. Stimulation of N6O2'-dibutyryl cyclic adenosine 3':5'-monophosphate of ectopic production of the free beta subunit of chorionic gonadotropin by a human brain tumor cell line. Cancer Res 1980, 40:4325-4328.
118. Cook AM, Huddart RA, Jay G, Norman A, Dearnaley DP, Horwich A. The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer. Br J Cancer 2000, 82:1952-1957. 2363245, 10864203.
119. Cole LA, Tanaka A, Kim GS, Park SY, Koh MW, Schwartz PE, Chambers JT, Nam JH. Beta-Core Fragment (beta-Core/UGF/UGP), a Tumor Marker: A 7-Year Report. Gynecol Oncol 1996, 60:264-270. 10.1006/gyno.1996.0036, 8631549.
120. Acevedo HF, Tong JY, Hartsock RJ. Human chorionic gonadotropin-beta subunit gene statement in cultured human fetal and cancer cells of different types and origins. Cancer 1995, 76:1467-1475. 10.1002/1097-0142(19951015)76:8<1467::AID-CNCR2820760826>3.0.CO;2-A, 8620425.
121. Nishimura R, Baba S, Hasegawa K, Kinugasa M, Okamura M, Kimura A, Ohtsu F, Takeuchi K. Characterization of immunoreactive hCG beta-subunit in cultured fluids of the cell lines derived from gynecologic malignant tumor. Nippon Sanka Fujinka Gakkai Zasshi 1990, 42:1471-1476.
122. Bepler G, Jaques G, Oie HK, Gazdar AF. Human chorionic gonadotropin and related glycoprotein hormones in lung cancer cell lines. Cancer Lett 1991, 58:145-150. 10.1016/0304-3835(91)90037-I, 1646686.
123. Ozturk M, Bellet D, Isselbacher KJ, Wands J. Ectopic beta-human chorionic gonadotropin production by a human hepatoma cell line (FOCUS): isolation and immunochemical characterization. Endocrinology 1987, 120:559-566. 10.1210/endo-120-2-559, 2433127.
124. Udagawa Y, Nozawa S, Chin K, Sakayori M, Mikami M, Ohta K, Tsukazaki K. Biological properties of two newly established cell lines (SKG- 3a, 3b) from a human uterine cervical epidermoid carcinoma. Nippon Sanka Fujinka Gakkai Zasshi 1984, 36:237-246.
125. Cole LA, Schwartz PE, Wong Y. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system: I Sensitivity and specificity comparison with other markers. Gynecol Oncol 1988, 31:82-90. 10.1016/0090-8258(88)90273-9, 3044936.
126. Acevedo HF, Krichevsky A, Campbell-Acevedo EA, Galyon JC, Buffo MJ, Hartsock RJ. Flow cytometry method for the analysis of membrane-associated human chorionic gonadotropin, its subunits, and fragments on human cancer cells. Cancer 1992, 69:1818-1828. 10.1002/1097-0142(19920401)69:7<1818::AID-CNCR2820690726>3.0.CO;2-7, 1372527.
127. Regelson W. Have we found the "definitive cancer biomarker"? The diagnostic and therapeutic implications of human chorionic gonadotropin-beta statement as a key to malignancy. Cancer 1995, 76:1299-1301. 10.1002/1097-0142(19951015)76:8<1299::AID-CNCR2820760802>3.0.CO;2-L, 8620401.
128. Wehmann RE, Nisula BC. Metabolic and renal clearance rates of purified human chorionic gonadotropin. J Clin Invest 1981, 68:184-194. 10.1172/JCI110234, 370786, 7251859.
129. Cole LA, Kardana A, Andrade-Gordon P, Gawinowicz MA, Morris JC, Bergert ER, O'Connor J, Birken S. The Heterogeneity of hCG: III. The occurrence, biological and immunological activities of nicked hCG. Endocrinology 1991, 129:1559-1567. 10.1210/endo-129-3-1559, 1714836.
130. Cole LA, Kardana A, Park S-Y, Braunstein G. The deactivation of hCG by nicking and dissociation. J Clin Endocrinol Metab 1993, 76:704-710. 10.1210/jc.76.3.704, 8445030.
131. Cole LA. The O-linked oligosaccharides are strikingly different on pregnancy and choriocarcinoma hCG. J Clin Endocrinol Metab 1987, 65:811-813. 10.1210/jcem-65-4-811, 3654923.
132. Iles RK. Human chorionic gonadotrophin and its fragments as markers of prognosis in bladder cancer. Tumor Marker Upd 1995, 7:161-166.
133. Butler SA, Iles RK. Biological function of the free ß-subunit: expression and treatment target in cancer. Human chorionic gonadotropin (hCG) 2010, 153-172. Burlington MA: Elsevier, Cole LA.
134. Iles RK. Ectopic hCGß expression by epithelial cancer: Malignant behavior metastasis and inhibition of tumor cell apoptosis. Mol Cell Endocrinol 2007, 260:264-270.
135. Cole LA, Birken S, Sutphen S, Hussa RO, Pattillo RA. Absence of the COOH-terminal peptide on ectopic human chorionic gonadotropin ß-subunit (hCG-ß). Endocrinology 1982, 110:2198-2200. 10.1210/endo-110-6-2198, 6176444.
136. Butler SA, Iles RK. Ectopic human chorionic gonadotrophin ß secretion by epithelial tumors and human chorionic gonadotrophin ß-induced apoptosis in Karposi's sarcoma, is there a connection?. Clin Cancer Res 2003, 9:4666-4673.
137. Carter WB, Sekharem M, Coppola D. Human chorionic gonadotropin induces apoptosis in breast cancer. Breast Cancer Res Treat 2006, 100:S243-S244.
138. Bellet D, Lazar V, Bleche I, Paradis V, Giovangrandi Y, Paterliru P. Malignant transformation of nontrophoblastic cells in association with the expression of chorionic gonadotropin ß genes normally transcribed in trophoblastic cells. Cancer Res 1997, 57:516-523.
139. Delves PJ, Iles RK, Roitt IM, Lund T. Designing a new generation of anti-hCG vaccines for cancer therapy. Mol Cell Endocrinol 2007, 260:276-281.
140. Iversen PL, Mourich DV, Moulton HM. Monoclonal antibodies to two epitopes of ß-human chorionic gonadotropin for the treatment of cancer. Curr Opin Mol Ther 2003, 5:156-160.
141. Moulton HM, Yoshihara PH, Mason DH, Iversen PL, Triozzi PL. Active specific immunotherapy with ß-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: Antibody response is associated with improved survival. Clin Cancer Res 2002, 8:2044-2051.
142. Morse MA, Chapman R, Powderly J, Blackwell K, Keler T, Green J, Riggs R, He LZ, Ramakrishna V, Vitale L, Zhao B, Butler SA, Hobeika A, Osada T, Davis T, Clay T, Lyerly HK. Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with toll-like receptor stimulation to induce immunity to self-antigens in cancer patients. Clin Cancer Res 2011, 17:4844-4853. 10.1158/1078-0432.CCR-11-0891, 21632857.
143. He L-Z, Ramakrishna V, Connolly JE, Wang X-T, Smith P, Jones CL, Valkova-Valchanova M, Arunakumari A, Treml JF, Goldstein J, Wallace PK, Keler T, Endres MJ. A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin β. Clin Cancer Res 2004, 10:1920-1924. 10.1158/1078-0432.CCR-03-0264, 15041707.
144. Triozzi PL, Stevens VC. Human chorionic gonadotropin as a target for cancer vaccines. Oncol Rep 1999, 6:7-17.